These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15470558)

  • 41. [Body-centered psychotherapy IKP: holistic psychotherapy of anxiety disorders].
    Maurer-Groeli Y
    Ther Umsch; 1997 Oct; 54(10):585-90. PubMed ID: 9432749
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Multidimensional counseling and intervention in anxiety problems in school].
    Jeck S
    Prax Kinderpsychol Kinderpsychiatr; 2003; 52(6):387-408. PubMed ID: 12951911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Multidimensional aspects in the therapy of anxiety].
    Zapotoczky HG
    Wien Klin Wochenschr; 1986 Oct; 98(19):663-7. PubMed ID: 3538671
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnosis and Management of Anxiety Disorders.
    Giacobbe P; Flint A
    Continuum (Minneap Minn); 2018 Jun; 24(3, BEHAVIORAL NEUROLOGY AND PSYCHIATRY):893-919. PubMed ID: 29851884
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pediatric management of anxiety disorders.
    Mattison RE
    Pediatr Ann; 1989 Feb; 18(2):114, 116-7, 121. PubMed ID: 2648276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Obsessive-compulsive disorder spectrum as a scientific "metaphor".
    Pallanti S; Hollander E
    CNS Spectr; 2008 Sep; 13(9 Suppl 14):6-15. PubMed ID: 18849906
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Meditation therapy for anxiety disorders.
    Krisanaprakornkit T; Krisanaprakornkit W; Piyavhatkul N; Laopaiboon M
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004998. PubMed ID: 16437509
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [How hypervigilance and hyperreactivity clinically described in anxiety expressed physiologically?].
    Zullino D; Khazaal Y; Hättenschwiler J; Borgeat F
    Sante Ment Que; 2004; 29(1):23-32. PubMed ID: 15470559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A pragmatic randomized controlled trial of group transdiagnostic cognitive-behaviour therapy for anxiety disorders in primary care: study protocol.
    Roberge P; Provencher MD; Gosselin P; Vasiliadis HM; Gaboury I; Benoit A; Antony MM; Chaillet N; Houle J; Hudon C; Norton PJ
    BMC Psychiatry; 2018 Oct; 18(1):320. PubMed ID: 30285672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Practice guidelines--therapy of anxiety and compulsive disorders. Recommendations for therapy of anxiety and compulsive disorders of the Drug Commission of the German Medical Society].
    Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):241-4. PubMed ID: 10802900
    [No Abstract]   [Full Text] [Related]  

  • 51. [Current and emerging features of obsessive-compulsive disorder--trends for the revision of DSM-5].
    Matsunaga H
    Seishin Shinkeigaku Zasshi; 2012; 114(9):1023-30. PubMed ID: 23198591
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
    Ninan PT; Rush AJ; Crits-Christoph P; Kornstein SG; Manber R; Thase ME; Trivedi MH; Rothbaum BO; Zajecka J; Borian FE; Keller MB
    J Clin Psychiatry; 2002 May; 63(5):434-41. PubMed ID: 12025827
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Affective styles in mood and anxiety disorders - Clinical validation of the "Affective Style Questionnaire" (ASQ).
    Totzeck C; Teismann T; Hofmann SG; von Brachel R; Zhang XC; Pflug V; Margraf J
    J Affect Disord; 2018 Oct; 238():392-398. PubMed ID: 29909302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mindfulness-based cognitive therapy for generalized anxiety disorder.
    Evans S; Ferrando S; Findler M; Stowell C; Smart C; Haglin D
    J Anxiety Disord; 2008 May; 22(4):716-21. PubMed ID: 17765453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The role of inhibition in obsessional-compulsive disorders].
    Dupuy M; Rouillon F; Bungener C
    Encephale; 2013 Feb; 39(1):44-50. PubMed ID: 23095598
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The structure and intensity of self-reported autonomic arousal symptoms across anxiety disorders and obsessive-compulsive disorder.
    Berle D; Starcevic V; Milicevic D; Hannan A; Dale E; Skepper B; Viswasam K; Brakoulias V
    J Affect Disord; 2016 Jul; 199():81-6. PubMed ID: 27093491
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A cognitive behavioral case formulation framework for treatment planning in anxiety disorders.
    Boschen MJ; Oei TP
    Depress Anxiety; 2008; 25(10):811-23. PubMed ID: 17385728
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Anxiety disorders. Causes, clinical picture and treatment].
    Zwanzger P; Deckert J
    Nervenarzt; 2007 Mar; 78(3):349-59; quiz 360. PubMed ID: 17279399
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Anxiety: personality, life style or illness?].
    Pelissolo A
    Encephale; 1998; 24(3):247-51. PubMed ID: 9696918
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cognitive behavioural therapy for anxiety disorders in children and adolescents.
    James A; Soler A; Weatherall R
    Cochrane Database Syst Rev; 2005 Oct; (4):CD004690. PubMed ID: 16235374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.